Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis

被引:0
作者
Antonia Dimitrakopoulou-Strauss
Ludwig G. Strauss
Gerlinde Egerer
Julie Vasamiliette
Thomas Schmitt
Uwe Haberkorn
Bernd Kasper
机构
[1] German Cancer Research Center,Medical PET Group
[2] University of Heidelberg,Biological Imaging (E0601), Clinical Cooperation Unit Nuclear Medicine
[3] University of Heidelberg,Department of Internal Medicine V
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2010年 / 37卷
关键词
F-FDG; Sarcomas; Kinetic modelling; Therapy monitoring; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1481 / 1489
页数:8
相关论文
共 85 条
  • [1] Grobmyer SR(2004)Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma Ann Oncol 15 1667-1672
  • [2] Maki RG(1991)The applications of PET in clinical oncology J Nucl Med 32 623-648
  • [3] Demetri GD(1997)Requirements and implementation of a flexible kinetic modeling tool J Nucl Med 38 1818-1823
  • [4] Mazumdar M(1998)A JAVA environment for medical image data analysis: initial application for brain PET quantitation Med Inform (Lond) 23 207-214
  • [5] Riedel E(2007)Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study Mol Imaging Biol 9 308-317
  • [6] Brennan MF(1993)Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography J Neurosci Methods 50 263-272
  • [7] Strauss LG(1991)Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs J Nucl Med 32 1432-1438
  • [8] Conti PS(2003)On the fractal nature of dynamic positron emission tomography (PET) studies World J Nucl Med 4 306-313
  • [9] Burger C(2005)Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas Ann Surg 241 286-294
  • [10] Buck A(2009)The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin Mar Drugs 7 331-340